GYROSCOPE THERAPEUTICS
Gyroscope is a clinical-stage gene therapy company focused on developing therapies and treating diseases of the eye. The company explores the convergence of advancements made in the understanding of the complement system’s impact on eye disease, the genetic basis of Age-related Macular Degeneration (AMD), and gene therapy as a mode of treatment delivery. Its lead investigational gene therapy, GT005, is a one-time therapy delivered under the retina. GT005 is designed to restore balance to an o... veractive complement system by increasing the production of the Complement Factor I protein. GT005 is currently being evaluated in a Phase I/II clinical trial called FOCUS and Phase II clinical trials called EXPLORE and HORIZON. Andrew Lotery, David Kavanagh, and Peter Lachmann co-founded Gyroscope Therapeutics in Stevenage, Herefordshire in 2016.
GYROSCOPE THERAPEUTICS
Industry:
Biotechnology Genetics Health Care Therapeutics
Founded:
2016-01-01
Address:
Stevenage, Herefordshire, United Kingdom
Country:
United Kingdom
Website Url:
http://www.gyroscopetx.com
Total Employee:
101+
Status:
Active
Contact:
+44 (0)1438 906770
Total Funding:
269.52 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress
Similar Organizations
Harpoon Therapeutics
Harpoon Therapeutics is a clinical-stage immunotherapy company developing novel T cell engagers (TriTACs) for the treatment of cancer.
NorthSea Therapeutics
NorthSea Therapeutics is a clinical-stage biotech company developing first-in class, oral, structurally-engineered lipid therapeutics.
Regulus Therapeutics
Regulus Therapeutics is a clinical stage biopharmaceutical company focused on the development and discovery of microRNA therapeutics.
Ribon Therapeutics
Ribon Therapeutics is a biotechnology company focused on the development of therapeutics treatments targeting stress support pathways.
Voyager Therapeutics
Voyager Therapeutics is a biotechnology company specializing in gene therapy and neurology.
Current Advisors List
Board_member
2021-03-01
Board_member
2021-03-01
Board_member
Board_observer
2021-03-26
Current Employees Featured
Andrew Lotery Professor of Ophthalmology, University of Southampton, Academic Founder @ Gyroscope Therapeutics
Professor of Ophthalmology, University of Southampton, Academic Founder
Peter Lachmann Academic Founder @ Gyroscope Therapeutics
Academic Founder
David Kavanagh Professor of Nephrology, Newcastle, Academic Founder @ Gyroscope Therapeutics
Professor of Nephrology, Newcastle, Academic Founder
2008-01-01
Khurem Farooq Chief Executive Officer @ Gyroscope Therapeutics
Chief Executive Officer
2018-10-01
Charlotte Arnold Vice President, Corporate Affairs @ Gyroscope Therapeutics
Vice President, Corporate Affairs
2020-07-01
Edward Lang Jr Chief Business Officer @ Gyroscope Therapeutics
Chief Business Officer
Arman Nadershahi Senior Director, Associate General Counsel @ Gyroscope Therapeutics
Senior Director, Associate General Counsel
2021-04-01
Founder
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2019-04-11 | Orbit Biomedical | Orbit Biomedical acquired by Gyroscope Therapeutics | N/A |
Investors List
Sanofi
Sanofi investment in Corporate Round - Gyroscope Therapeutics
Syncona Partners LLP
Syncona Partners LLP investment in Series C - Gyroscope Therapeutics
Cambridge Innovation Capital
Cambridge Innovation Capital investment in Series C - Gyroscope Therapeutics
Sofinnova Investments
Sofinnova Investments investment in Series C - Gyroscope Therapeutics
Tetragon Financial Group Limited
Tetragon Financial Group Limited investment in Series C - Gyroscope Therapeutics
T. Rowe Price
T. Rowe Price investment in Series C - Gyroscope Therapeutics
Forbion Capital Partners
Forbion Capital Partners investment in Series C - Gyroscope Therapeutics
Fosun Pharma
Fosun Pharma investment in Series C - Gyroscope Therapeutics
Cambridge Innovation Capital
Cambridge Innovation Capital investment in Series B - Gyroscope Therapeutics
Syncona Partners LLP
Syncona Partners LLP investment in Series B - Gyroscope Therapeutics
Official Site Inspections
http://www.gyroscopetx.com Semrush global rank: 3.26 M Semrush visits lastest month: 5.05 K
- Host name: 104.18.26.220
- IP address: 104.18.26.220
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Gyroscope Therapeutics"
Gyroscope Therapeutics - Crunchbase Company Profile & Funding
Gyroscope is a clinical-stage gene therapy company focused on developing therapies and treating diseases of the eye. The company explores the convergence of advancements made in the …See details»
Gyroscope Therapeutics - Overview, News & Similar companies
View Gyroscope Therapeutics (www.gyroscopetx.com) location in Hertfordshire, United Kingdom , revenue, industry and description. Find related and similar companies as well as employees …See details»
Gyroscope - Company Profile - Tracxn
Dec 6, 2024 Gyroscope - Developer of gene therapies for eye diseases. Acquired by Novartis. Raised a total funding of $255M over 5 rounds from 11 investors. Gyroscope has 942 …See details»
Gyroscope Therapeutics Overview | SignalHire Company Profile
Organization Website: gyroscopetx.com : Social Links: Contact Email [email protected] Phone Number +44 (0)1438 906770: Gyroscope Therapeutics industries Biotech: Headquarters …See details»
Gyroscope Company Profile 2024: Valuation, Investors ... - PitchBook
Gyroscope General Information Description. Developer of genetically-defined therapies designed to serve patients suffering from retinal diseases. The company's gene therapy helps to treat a …See details»
Gyroscope Therapeutics Company Profile | Management and
Smith@gyroscopetx.com: Gyroscope Therapeutics Top Competitors. Company Employees Revenue Top technologies; Galvani Bioelectronics Ltd. 40: $6.1 M: Oxford BioDynamics PLC. …See details»
Gyroscope Therapeutics Financial Overview, Employee Count, and ...
About Gyroscope Therapeutics, a Novartis company:Gyroscope Therapeutics is a clinical-stage gene therapy company developing gene therapy beyond rare disease to treat diseases of the …See details»
Gyroscope Therapeutics - Org Chart, Teams, Culture & Jobs - The …
View Gyroscope Therapeutics' up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»
Gyroscope Therapeutics Company Profile - Craft
See insights on Gyroscope Therapeutics including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
Gyroscope Therapeutics - Employees, Contact info, Overview - Wiza
Apr 30, 2024 View info about Gyroscope Therapeutics (gyroscopetx.com). Gyroscope Therapeutics is a company located in London, England, United Kingdom. Find employees, …See details»
Gyroscope Therapeutics (UK) Funding: $269.5M - Medical Startups
Dec 10, 2024 Gyroscope is an ophthalmology company developing gene therapies for the treatment of eye diseases linked to an unbalanced complement...See details»
Gyroscope Therapeutics - Contacts, Employees, Board Members, …
Gyroscope Therapeutics is a clinical-stage gene therapy company focused on developing therapies and treating diseases of the eye.See details»
Gyroscope’s Competitors, Revenue, Number of Employees ... - Owler
Gyroscope’s Profile, Revenue and Employees. Gyroscope is an England-based pharmaceutical company that researches and develops gene therapies for the treatment of eye disorders. …See details»
Gyroscope Therapeutics merges with Orbit Biomedical creating a …
Apr 12, 2019 Gyroscope is a private company headquartered in London, UK and is supported by experts in complement biology, AMD and gene therapy. Investors include Syncona Ltd., …See details»
Gyroscope Therapeutics acquires Orbit Biomedical - 2019-04-11 ...
Apr 11, 2019 Acquiring Organization: Gyroscope Therapeutics Gyroscope Therapeutics is a clinical-stage gene therapy company focused on developing therapies and treating diseases of …See details»
Gyroscope Therapeutics to be Acquired for up to $1.5 Billion
LONDON – 22 December 2021 – Gyroscope Therapeutics Holdings plc (“Gyroscope”), a clinical-stage gene therapy company focused on diseases of the eye, today announced an agreement …See details»
Gyroscope Announces Appointment of Leaders in Retinal Disease …
Apr 8, 2020 Full biographies for members of the Gyroscope Advisory Boards are available at www.gyroscopetx.com. About Gyroscope Therapeutics: Vision for Life Gyroscope …See details»
Gyroscope Therapeutics Announces $148 Million Raised in Series …
Mar 26, 2021 For more information visit: www.gyroscopetx.com and follow us on Twitter (@GyroscopeTx) and on LinkedIn. 1 National Eye Institute. Age-Related Macular Degeneration.See details»
Gyroscope Therapeutics Announces Sanofi Investment of up to …
Aug 11, 2021 Investment Further Validates Potential of Investigational Gene Therapy GT005 in Geographic Atrophy and Supports Ongoing Phase II Development ProgrammeSee details»
Gyroscope Therapeutics Announces Appointment of Tony Adamis …
Jul 12, 2021 Gyroscope Therapeutics Holdings plc, a clinical-stage gene therapy company focused on diseases of the eye, today announced the appointment of biotech industry veteran …See details»